The Attractiveness of Investing In GoodRx Holdings Inc. (GDRX) is Growing

0
23

In the meantime, Citigroup initiated its GoodRx Holdings Inc. [GDRX] rating to a Buy in a research note published on Tuesday, December 01, 2022; the price target was $7. PT values the company’s stock at a premium of 25.57 to its Tuesday closing price. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early November from “an Underweight” to “a Neutral”. KeyBanc Capital Markets began covering GDRX with “Sector weight” recommendation on September 16, 2022. Truist started covering the stock on September 07, 2022. It rated GDRX as “a Hold”.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Price Performance Review of GDRX

On Tuesday, GoodRx Holdings Inc. [NASDAQ:GDRX] saw its stock fall -7.46% to $5.21. On the same session, the stock had its day’s lowest price of $5.165, but rose to a high of $5.625. Over the last five days, the stock has lost -2.98%. GoodRx Holdings Inc. shares have risen nearly 11.80% since the year began. Nevertheless, the stocks have fallen -77.84% over the past one year. While a 52-week high of $30.89 was reached on 01/23/23, a 52-week low of $3.82 was recorded on 01/06/23. SMA at 50 days reached $4.98, while 200 days put it at $7.01. A total of 1.71 million shares were traded, compared to the trading of 1.38 million shares in the previous session.

Levels Of Support And Resistance For GDRX Stock

The 24-hour chart illustrates a support level at 5.04, which if violated will result in even more drops to 4.87. On the upside, there is a resistance level at 5.50. A further resistance level may holdings at 5.79. The Relative Strength Index (RSI) on the 14-day chart is 53.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.23, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 43.04%. Stochastics %K at 76.88% indicates the stock is a holding.

How much short interest is there in GoodRx Holdings Inc.?

A steep rise in short interest was recorded in GoodRx Holdings Inc. stocks on Oct 13, 2022, growing by 0.36 million shares to a total of 12.2 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 11.84 million shares. There was a rise of 2.95%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 19.53% of the overall stock float, the days-to-cover ratio (short ratio) rose to 6.32.

GoodRx Holdings Inc. [GDRX] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 7,757,523 shares, or roughly 9.41% of the outstanding GDRX shares. In other words, the investor’s shares have risen by 739,017 from its previous 13-F filing of 7018506.0. Additionally, Millennium Management LLC increased 107.72% of its stake after which the total value it holdings stand at $20,487,834, while Light Street Capital Management L reduced -9.45% of its stake to hold $19.53 million in the firm. Over the last quarter, Marshall Wace LLP purchased 55,218 shares of GoodRx Holdings Inc., while Renaissance Technologies LLC bought -1,024,000 shares. At present, Petrus Securities LP is holding 2,163,566 shares valued at $10.08 million. BlackRock Fund Advisors owned 1,703,329 shares of the company at the time of its most recent 13F filing, worth $7.94 million.

According to FactSet, GoodRx Holdings Inc.’s share price will average $6.97 in the next year, based on opinions of analysts polled by the firm. This is up nearly 24.33 percent from its previous closing price of $5.63. Analysts expect GoodRx Holdings Inc. stock to reach the higher price of $10.00, while the lowest price estimate is $4.50. However, 22 analysts have rated GDRX stock as a Hold in their predictions for 2023. The most recent change occurred on August 12, 2022 when DA Davidson began covering the stock and recommended ‘”a Neutral”‘ rating along with a $8 price target.

LEAVE A REPLY

Please enter your comment!
Please enter your name here